NEW HAVEN, Conn., Oct. 15, 2024 (GLOBE NEWSWIRE) — Allyx Therapeutics announced today that it has been awarded a $3.3 million grant from the National Institutes of Health as part of its Small Business Innovation Research Commercial Readiness Pilot program. This funding will support further investigation of Allyx’s lead clinical asset, ALX-001, a highly-selective, first-in-class, […]
LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first patient has been dosed in the Phase I/II clinical trial of AMT-162 for the treatment of amyotrophic lateral sclerosis (ALS) caused by
Topline Results Expected in Q1 2025 Lutris Pharma, a clinical stage biopharmaceutical company focused onimprovinganti-cancertherapies byreducingcutaneous doselimiting toxicity, today announced that it has completed enrollment in the phase 2 trial of lead compound, LUT014, a topically-applied novel B-Raf inhibitor, for patients with metastatic colorectal cancer (mCRC) treated with epidermal growth factor receptor (EGFR) inhibitor therapy
Local home services provider to donate $50 to Seattle Children’s Hospital for each goal scored Harts Plumbers, Electricians & HVAC Technicians, a top-rated home services provider founded in 2013, remains dedicated to giving back to their local community by continuing its partnership with the Seattle Kraken, an alliance that helped generate $10,850 for Seattle Children’s
PETAH TIKVA, Israel, Oct. 15, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that it has been awarded approximately $15 million in orders from several major satellite operators for its advanced satellite communications solutions for GEO, MEO and LEO
NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Light & Wonder, Inc. ("Light & Wonder" or "the Company") (NASDAQ:LNW). Investors who purchased Light & Wonder securities are encouraged to obtain additional information and assist the investigation by visiting
NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards" or "the Company") (NYSE:EW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants
R3 Wound Care And Hyperbaric Executive Promoted From Previous Post As Company's Manager of Human Resources DALLAS-FORT WORTH, TX / ACCESSWIRE / October 15, 2024 / R3 Wound Care & Hyperbarics, a portfolio company of 3 Rivers Capital and a leading provider of advanced wound care treatments, has promoted David Underwood to Senior Director of
NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against United Parcel Service, Inc. ("UPS" or "the Company") (NYSE:UPS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your WEBTOON Entertainment Inc. (NASDAQ:WBTN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/webtoon-entertainment-inc-lawsuit-submission-form?prid=108424&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call